Shanghai Biotechnology Corporation

Shanghai Biotechnology Corporation (SBC) is a leading contract research organization (CRO) specializing in multi-omics and precision medicine, headquartered in Shanghai, China. Established in 2008, the company serves as the commercial arm of the National Engineering Research Center for Biochips at Shanghai. SBC offers a comprehensive range of services, including next-generation sequencing (NGS), microarray analysis, proteomics, and advanced bioinformatics, to global pharmaceutical companies and academic research institutions. The company is recognized for its high-throughput screening capabilities and certified clinical diagnostic services, holding international accreditations such as CAP and CLIA. SBC plays a pivotal role in the discovery of biomarkers and the development of molecular diagnostics to support personalized healthcare.